- call +1-201-465-4211
- email sales@mrinsights.biz
Intrathecal administration is a route of administration for drugs via an injection into the spinal canal, or into the subarachnoid space so that it reaches the cerebrospinal fluid (CSF) and is useful in spinal anaesthesia, chemotherapy, or pain management applications. This route is also used to introduce drugs that fight certain infections, particularly post-neurosurgical. The drug needs to be given this way to avoid being stopped by the blood brain barrier. The same drug given orally must enter the blood stream and may not be able to pass out and into the brain. Drugs given by the intrathecal route often have to be compounded specially by a pharmacist or technician because they cannot contain any preservative or other potentially harmful inactive ingredients that are sometimes found in standard injectable drug preparations.
Scope of the Report:
The worldwide market for Intrathecal Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Intrathecal Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Medtronic
Jazz Pharmaceuticals
West Ward Pharmaceutical
Saol Therapeutics
Piramal Critical Care
Fresenius Kabi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Baclofen injection
Ziconotide Intrathecal Infusion
Morphine injection
Market Segment by Applications, can be divided into
Adult
Child & Teen
There are 15 Chapters to deeply display the global Intrathecal Drug market.
Chapter 1, to describe Intrathecal Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Intrathecal Drug, with sales, revenue, and price of Intrathecal Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Intrathecal Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Intrathecal Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Intrathecal Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Intrathecal Drug Introduction
1.2 Market Analysis by Type
1.2.1 Baclofen injection
1.2.2 Ziconotide Intrathecal Infusion
1.2.3 Morphine injection
1.3 Market Analysis by Applications
1.3.1 Adult
1.3.2 Child & Teen
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Business Overview
2.1.2 Intrathecal Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Medtronic Intrathecal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Jazz Pharmaceuticals
2.2.1 Business Overview
2.2.2 Intrathecal Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Jazz Pharmaceuticals Intrathecal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 West Ward Pharmaceutical
2.3.1 Business Overview
2.3.2 Intrathecal Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 West Ward Pharmaceutical Intrathecal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Saol Therapeutics
2.4.1 Business Overview
2.4.2 Intrathecal Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Saol Therapeutics Intrathecal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Piramal Critical Care
2.5.1 Business Overview
2.5.2 Intrathecal Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Piramal Critical Care Intrathecal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Fresenius Kabi
2.6.1 Business Overview
2.6.2 Intrathecal Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Fresenius Kabi Intrathecal Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Intrathecal Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Intrathecal Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Intrathecal Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Intrathecal Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Intrathecal Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Intrathecal Drug Market Analysis by Regions
4.1 Global Intrathecal Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Intrathecal Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Intrathecal Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Intrathecal Drug Sales and Growth Rate (2013-2018)
4.3 Europe Intrathecal Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Intrathecal Drug Sales and Growth Rate (2013-2018)
4.5 South America Intrathecal Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Intrathecal Drug Sales and Growth Rate (2013-2018)
5 North America Intrathecal Drug by Countries
5.1 North America Intrathecal Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Intrathecal Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Intrathecal Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Intrathecal Drug Sales and Growth Rate (2013-2018)
5.3 Canada Intrathecal Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Intrathecal Drug Sales and Growth Rate (2013-2018)
6 Europe Intrathecal Drug by Countries
6.1 Europe Intrathecal Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Intrathecal Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Intrathecal Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Intrathecal Drug Sales and Growth Rate (2013-2018)
6.3 UK Intrathecal Drug Sales and Growth Rate (2013-2018)
6.4 France Intrathecal Drug Sales and Growth Rate (2013-2018)
6.5 Russia Intrathecal Drug Sales and Growth Rate (2013-2018)
6.6 Italy Intrathecal Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Intrathecal Drug by Countries
7.1 Asia-Pacific Intrathecal Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Intrathecal Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Intrathecal Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Intrathecal Drug Sales and Growth Rate (2013-2018)
7.3 Japan Intrathecal Drug Sales and Growth Rate (2013-2018)
7.4 Korea Intrathecal Drug Sales and Growth Rate (2013-2018)
7.5 India Intrathecal Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Intrathecal Drug Sales and Growth Rate (2013-2018)
8 South America Intrathecal Drug by Countries
8.1 South America Intrathecal Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Intrathecal Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Intrathecal Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Intrathecal Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Intrathecal Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Intrathecal Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Intrathecal Drug by Countries
9.1 Middle East and Africa Intrathecal Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intrathecal Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Intrathecal Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Intrathecal Drug Sales and Growth Rate (2013-2018)
9.3 UAE Intrathecal Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Intrathecal Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Intrathecal Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Intrathecal Drug Sales and Growth Rate (2013-2018)
10 Global Intrathecal Drug Market Segment by Type
10.1 Global Intrathecal Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Intrathecal Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Intrathecal Drug Revenue and Market Share by Type (2013-2018)
10.2 Baclofen injection Sales Growth and Price
10.2.1 Global Baclofen injection Sales Growth (2013-2018)
10.2.2 Global Baclofen injection Price (2013-2018)
10.3 Ziconotide Intrathecal Infusion Sales Growth and Price
10.3.1 Global Ziconotide Intrathecal Infusion Sales Growth (2013-2018)
10.3.2 Global Ziconotide Intrathecal Infusion Price (2013-2018)
10.4 Morphine injection Sales Growth and Price
10.4.1 Global Morphine injection Sales Growth (2013-2018)
10.4.2 Global Morphine injection Price (2013-2018)
11 Global Intrathecal Drug Market Segment by Application
11.1 Global Intrathecal Drug Sales Market Share by Application (2013-2018)
11.2 Adult Sales Growth (2013-2018)
11.3 Child & Teen Sales Growth (2013-2018)
12 Intrathecal Drug Market Forecast (2018-2023)
12.1 Global Intrathecal Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Intrathecal Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Intrathecal Drug Market Forecast (2018-2023)
12.2.2 Europe Intrathecal Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Intrathecal Drug Market Forecast (2018-2023)
12.2.4 South America Intrathecal Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Intrathecal Drug Market Forecast (2018-2023)
12.3 Intrathecal Drug Market Forecast by Type (2018-2023)
12.3.1 Global Intrathecal Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Intrathecal Drug Market Share Forecast by Type (2018-2023)
12.4 Intrathecal Drug Market Forecast by Application (2018-2023)
12.4.1 Global Intrathecal Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Intrathecal Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Intrathecal Drug Picture
Table Product Specifications of Intrathecal Drug
Figure Global Sales Market Share of Intrathecal Drug by Types in 2017
Table In
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
